Drug-resistant Neisseria gonorrhoeae: latest developments

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Gonorrhea is a prevalent sexually transmitted infection, ranking as the second most reported notifiable disease in the U.S. and increasing in Europe.
• The emergence of multidrug-resistant Neisseria gonorrhoeae poses a significant public health challenge worldwide.

Purpose of the Study:

• To review the current status of drug resistance in Neisseria gonorrhoeae.
• To evaluate the future treatment prospects for gonorrhea in light of antimicrobial resistance.

Main Methods:

• An extensive literature search was performed to gather recent research on gonorrhea drug resistance and treatment guidelines.
• Analysis of data from established surveillance programs in the EU, U.S., and U.K. on gonococcal resistance patterns.

Main Results:

• Neisseria gonorrhoeae has demonstrated resistance to all currently available antimicrobial agents.
• Increasing resistance to ceftriaxone, cefixime, and azithromycin is threatening established gonorrhea treatment protocols globally.

Conclusions:

• The rise of resistant gonorrhea strains necessitates the development of novel therapeutic agents and treatment strategies.
• Continued surveillance and research are critical to combatting this 'superbug' and preserving effective gonorrhea treatment options.